logo
Aid groups warn of attacks on Sudan's hospitals as disease outbreaks and atrocities mount

Aid groups warn of attacks on Sudan's hospitals as disease outbreaks and atrocities mount

Yahoo9 hours ago
CAIRO (AP) — Humanitarian organizations are sounding the alarm over attacks on healthcare facilities across Sudan, warning that they are happening amid what they describe as ongoing mass atrocities against civilians.
Doctors without Borders — also known as Médecins Sans Frontières or MSF — said Thursday that 70% of medical facilities in Sudan have either closed or are barely operational with no end to the war in sight.
Sudan's civil war broke out in April 2023 after simmering tensions between the Sudanese army and its paramilitary Rapid Support Forces (RSF), escalated to fighting across the country. Some 40,000 people have been killed and nearly 13 million displaced, including to other countries, according to U.N. agencies. War has left many facing food insecurity and risk of famine and exposure to disease outbreaks like cholera, which remains hard to contain due to Sudan's collapsed healthcare system.
In a report released Thursday titled 'Besieged, Attacked, Starved', MSF warned that access to healthcare is nearly impossible due to systematic attacks, while the remaining operational facilities remain under constant threat.
'We call to all warring parties to stop violence against the civilian health facilities and civilian infrastructure and to facilitate a large-scale humanitarian response,' said Michel-Olivier Lacharité, MSF's head of emergency operations in a news conference presenting the report.
Echoing MSF's concerns, Save the Children, warned Thursday that attacks on hospitals nearly tripled after two years of war. The group said in a statement that at least 933 people, including children, were killed during the first half of 2025.
This figure is a 60-fold increase over the deaths recorded during the same period of the previous year, according to the group. Those killed were either seeking medical care or accompanying a loved one in a hospital.
Major hospitals, clinics, health facilities, ambulances and medical convoys all saw fatal attacks in a country where half the population requires humanitarian assistance, according to Save the Children.
'We are concerned that in most cases, the hospitals that have come under fire also happen to be the only remaining hospitals in those areas, putting healthcare out of reach for millions, including displaced people,' said Francesco Lanino, deputy country director of programs and operations for Save the Children in Sudan.
MSF particularly warned against violence in El Fasher city, the capital of North Darfur province, that made it near impossible for residents there and nearby displacement camps to access healthcare.
As of April, only one hospital with surgical capacity remained partially operational, serving an estimated population of over one million. Over the past year, many patients and their caretakers have been killed while inside an MSF-supported medical facility.
MSF urged the warring parties to 'halt indiscriminate and ethnically targeted violence and facilitate an immediate large-scale humanitarian response', particularly referring to threats of attacks on the hundreds of thousands of people in El Fasher, where fighting intensified since May 2024.
Last month, Sudan's military accepted a U.N. proposal for a week-long ceasefire in El Fasher to allow aid delivery. However, the RSF did not explicitly agree to the truce and engaged in renewed clashes with the army in the southern part of the city this week.
MSF urged the international community — especially countries engaging with both the Sudanese army and the RSF — to take stronger action to address the crisis in Sudan.
'They must use all the leverage to prevent further mass atrocities. They must place protection of civilians at the core of their engagement with the warring parties,' said Christopher Lockyear, secretary general of MSF International, on Thursday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Digital Twins: Medicine's New Crystal Ball?
Digital Twins: Medicine's New Crystal Ball?

Medscape

time8 minutes ago

  • Medscape

Digital Twins: Medicine's New Crystal Ball?

Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient's body, body parts, specific organs, and systems, such as the circulatory and nervous systems. Functional modeling of the state and behavior of the body or its components has the potential to provide information for clinical and research applications. The goal is to simulate how an organ, system, or even the entire body responds to stimuli and circumstances of clinical relevance to the patient, thereby deriving useful conclusions. These models may be descriptive, predictive, prescriptive, or even generative, capable of filling in missing or unavailable data. A central challenge is accurately replicating the physicochemical, physiological, anatomical, and, when needed, psychological attributes relevant to each specific use case. Building clinically useful digital twins depends on integrating diverse data sources, which is a technically complex task. However, when successful, it enables a dynamic 'dialogue' with the model to evaluate its current state, forecast evolution, and simulate responses to interventions such as therapies. It is important to emphasize that digital twin simulations are tailored to individual patients — they do not represent a generic or archetypal patient but instead aim to create a personalized model for a specific individual. One example is a project led by the Spanish National Cancer Research Centre (CNIO), which is developing digital twins of women with advanced cancer using artificial intelligence. This initiative, titled 'High-Definition Oncology in Women's Cancer,' is part of the Precision Medicine Infrastructure Associated With Science and Technology program. These digital twins consist of multiple layers of information integrated into a single model that reflects reality for a specific application. In the aforementioned project, a wide range of data were incorporated into the digital twin models, spanning tumor metabolism, gene and protein expression, physiological indicators such as circadian rhythms, heart rate, and physical activity, emotional well-being, and conventional clinical data from diagnostics to treatment protocols. Adding more 'layers' of information enhances the model complexity and accuracy, enabling incremental improvements and expanded functionality. A notable innovation in this case is the biological clock model developed by the CNIO, which estimates a patient's biologic age. This can help assess whether biologic aging accelerates or slows during disease progression, providing insight into the effect of treatment. This may guide clinicians in adjusting treatment intensity or modifying therapeutic combinations according to the patient's evolving biologic state. The layers of information used and their integration are key aspects of each type of digital twin, ensuring that it is not only functional but also clinically relevant. In many ways, digital twins serve as 'maps,' both literal and figurative. In the most direct sense, they can guide the planning of physical interventions such as surgical procedures. Broader Applications In addition to simulating the effects of therapies, digital twins can model the natural progression of diseases and support long-term care planning. They may help anticipate the onset of certain conditions, particularly hereditary diseases, when risk factors are present but symptoms have yet to appear. These models offer valuable tools for proactive risk prevention and management. In the context of prevention, the ability to present a stronger, data-driven case — even if derived from simulations — could help persuade patients and improve adherence to preventive care guidelines. Integration With Medical Devices From a certain perspective, digital twins resemble a technology-driven 'crystal ball.' Once refined, these models could allow clinicians to explore alternative therapeutic scenarios and identify the most effective treatment strategies. This minimizes reliance on trial and error, enabling faster data-driven decisions in a controlled simulation environment, a kind of clinical sandbox. A key area of synergy lies between the digital twins and medical devices. Wearable technologies, for instance, can supply real-time or periodic health data that dynamically update a patient's digital twin. Conversely, digital twins can enhance the medical device field by enabling the optimization of device configurations or implant placements. Their integration into the body and potential physiological effects can be modeled and simulated in advance, allowing for more precise and personalized interventions. These models also help to synthesize and manage large volumes of complex data. By serving as intelligent filters, they reduce the cognitive load on clinicians, offering clear visualizations and simulations that support more confident decision-making, especially in complex or uncertain clinical situations. Applications and Regulatory Considerations Digital twins hold promise across a wide range of medical applications, from early diagnosis, prognosis, and personalized therapy selection to treatment monitoring and relapse prevention. In fields such as neurology, cardiology, and oncology, these models have already shown potential. Digital twins have already been applied in neurology, cardiology, and oncology. Focusing on Spain-based developments, two recent advances featured by Univadis Spain , a Medscape Network platform, stand out: One involves using digital twins for research on the human brain to uncover mechanisms linked to psychosis remission, and the other demonstrates the use of digital twin improvements in the diagnosis of premature ventricular contractions. While the field is evolving rapidly, it remains in its early stages. Although technical hurdles and regulatory complexities are expected, the long-term potential is significant. Digital twins could enable faster and safer evaluations of multiple treatment paths and support virtual experimentation in a risk-free environment. One major challenge is clinical validation. Digital twins must be tested with real-world longitudinal data and demonstrate that their predictions provide added value compared to current clinical guidelines. Equally crucial is the development of interoperable, cross-border data infrastructure that enables scalable, coordinated adoption across healthcare systems worldwide. A final and crucial aspect to consider is data privacy, ownership, and ethical use of digital twins. Beyond the data itself, fundamental questions arise about digital twin models: Who owns a person's digital twin? Should these models be transferable, and if so, under what conditions? Informed consent is central to addressing these issues and ensuring the responsible use of digital twin technologies in clinical practice. The use of digital twins in clinical trials is already being explored, and their potential extends further to medical training and patient education, particularly in explaining therapeutic options. As technology evolves, the range of future applications continues to expand.

Astrana Health completes acquisition of Prospect Health for $708m
Astrana Health completes acquisition of Prospect Health for $708m

Yahoo

time3 hours ago

  • Yahoo

Astrana Health completes acquisition of Prospect Health for $708m

US-based Astrana Health has closed its acquisition of Prospect Health, a care delivery network, for a total purchase price of $708m. With a network of more than 11,000 providers, Prospet Health offers coordinated care to approximately 600,000 members. The network covers various states in the US, including Arizona, Rhode Island, Southern California, and Texas, serving Medicaid, Medicare Advantage, and Commercial business lines. Prospect Health's operations include a health plan, a management services organisation, a speciality pharmacy, and an acute care hospital. The acquisition price reflects a decrease from the initially stated $745m in November 2024. Astrana president and CEO Brandon Sim said: "We are excited to welcome Prospect Health's physicians, providers, and team members to Astrana Health. "Together, we will further accelerate our mission to drive consistent, coordinated, high-quality patient outcomes at scale, ultimately driving greater value across the healthcare ecosystem." Astrana projects that Prospect Health will contribute a total revenue of approximately $1.2bn and $81m in adjusted EBITDA annually. In addition, Astrana anticipates achieving $12m to $15m of synergies within the next one to one-and-a-half years. The company has updated its 2025 full-year guidance to a revenue range of $3.1bn to $3.3bn and adjusted EBITDA between $215m and $225m, considering Prospect Health's half-year contribution. Following the transaction, Astrana's net debt is expected to be approximately $700m. The company's management is focused on lessening the net leverage ratio to below 2.5 times within the next one to one-and-a-half years. Truist Securities led a consortium of banks that offered the term loan for the purchase. J P Morgan acted as the exclusive financial adviser to Astrana during the transaction. The acquisition follows Astrana's previous acquisition of Collaborative Health Systems in October last year, which also aimed to broaden its care delivery capabilities. "Astrana Health completes acquisition of Prospect Health for $708m" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19
QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19

Yahoo

time3 hours ago

  • Yahoo

QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19

NOVATO, Calif., July 04, 2025--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that its 2025 Annual Meeting of Stockholders will be held as a virtual meeting on Tuesday, August 19, 2025, at 1:00 p.m. EDT (10:00 a.m. PDT). Stockholders of record at the close of business on July 16, 2025 shall be entitled to vote at the 2025 Annual Meeting. Information about the virtual meeting webcast and instructions for how stockholders can participate in the 2025 Annual Meeting will be included in the definitive proxy statement to be filed with the Securities and Exchange Commission and will be available on the "Investors" section of QT Imaging's website at About QT Imaging Holdings, Inc. QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient's experience. For more information on QT Imaging Holdings, Inc., please visit the company's website at Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "will," and "expect," or the negative thereof or comparable terminology, and include (without limitation) statements regarding the date of its annual meeting of stockholders. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the QT Imaging Breast Acoustic CT Scanner, the ability of QT Imaging Holdings to sell and deploy the QT Imaging Breast Acoustic CT Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and "bring to market" plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading "Risk Factors" and in other sections of QT Imaging Holding's filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement. View source version on Contacts For investor and media inquiries, please contact: Stephen Kilmer Head of Investor Stas Budagov Chief Financial Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store